Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › relugolix

relugolix

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of relugolix

11 trials tracked of relugolix: 8 in phase 3 or 4 and 3 with published results. The most-cited published study has 50 citations.

11Trials tracked
8Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 3 8 Phase 2 2 Other / NA 1
  1. Phase 3 SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain Completed · 50 cited
  2. Phase 3 LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Completed · 41 cited
  3. Phase 3 Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Completed · 22 cited
  4. Phase 3 A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids Completed
  5. Phase 3 A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer Completed
  6. Phase 3 A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids Completed
Show 5 more trials
  1. Phase 3 LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Completed
  2. Phase 3 LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Completed
  3. Phase 2 A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer Completed
  4. Phase 2 A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases Completed
  5. N/A Description of Relugolix Use in Patients With Prostate Cancer Within the VHA Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.